Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matilde Capi

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Expert Opinion on Pharmacotherapy|June 19, 2014
Sodium channel antagonists for the treatment of migraineLorenza Chiossi, Andrea Negro, Matilde Capi, et al.
Expert Review of Neurotherapeutics|October 9, 2012
Deciphering the task of N-acetyl aspartate in migraineLuana Lionetto, Matilde Capi, Gabriele Vignaroli, et al.
Expert Opinion on Pharmacotherapy|February 4, 2020
Ubrogepant for the treatment of migraineMartina Curto, Matilde Capi, Fabiola Cipolla, et al.
International Journal of Environmental Research and Public Health|April 15, 2020
Persistent Post-Traumatic Headache and Migraine: Pre-Clinical ComparisonsMatilde Capi, Leda Marina Pomes, Giulia Andolina, et al.
Therapeutic Advances in Neurological Disorders|September 2, 2016
Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent responseMatilde Capi, Martina Curto, Luana Lionetto, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 16, 2016
Choosing the safest acute therapy during chronic migraine prophylactic treatment: pharmacokinetic and pharmacodynamic considerationsLuana Lionetto, Marina Borro, Martina Curto, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 17, 2016
Acute, transitional and long-term cluster headache treatment: pharmacokinetic issuesFernando de Andrés, Luana Lionetto, Martina Curto, et al.
Expert Review of Clinical Pharmacology|June 22, 2019
Fremanezumab for the preventive treatment of migraine in adultsLuana Lionetto, Martina Curto, Giusy Ylenia Cisale, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 27, 2018
Pharmacogenetic considerations for migraine therapiesMatilde Capi, Giovanna Gentile, Luana Lionetto, et al.
Expert Opinion on Pharmacotherapy|November 27, 2019
Profiling lasmiditan as a treatment option for migraineMartina Curto, Fabiola Cipolla, Giusy Ylenia Cisale, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Expert Opinion on Pharmacotherapy|June 19, 2014
Sodium channel antagonists for the treatment of migraineLorenza Chiossi, Andrea Negro, Matilde Capi, et al.
Expert Review of Neurotherapeutics|October 9, 2012
Deciphering the task of N-acetyl aspartate in migraineLuana Lionetto, Matilde Capi, Gabriele Vignaroli, et al.
Expert Opinion on Pharmacotherapy|February 4, 2020
Ubrogepant for the treatment of migraineMartina Curto, Matilde Capi, Fabiola Cipolla, et al.
International Journal of Environmental Research and Public Health|April 15, 2020
Persistent Post-Traumatic Headache and Migraine: Pre-Clinical ComparisonsMatilde Capi, Leda Marina Pomes, Giulia Andolina, et al.
Therapeutic Advances in Neurological Disorders|September 2, 2016
Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent responseMatilde Capi, Martina Curto, Luana Lionetto, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 16, 2016
Choosing the safest acute therapy during chronic migraine prophylactic treatment: pharmacokinetic and pharmacodynamic considerationsLuana Lionetto, Marina Borro, Martina Curto, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 17, 2016
Acute, transitional and long-term cluster headache treatment: pharmacokinetic issuesFernando de Andrés, Luana Lionetto, Martina Curto, et al.
Expert Review of Clinical Pharmacology|June 22, 2019
Fremanezumab for the preventive treatment of migraine in adultsLuana Lionetto, Martina Curto, Giusy Ylenia Cisale, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 27, 2018
Pharmacogenetic considerations for migraine therapiesMatilde Capi, Giovanna Gentile, Luana Lionetto, et al.
Expert Opinion on Pharmacotherapy|November 27, 2019
Profiling lasmiditan as a treatment option for migraineMartina Curto, Fabiola Cipolla, Giusy Ylenia Cisale, et al.
Pageof 3